
    
      Investigators designed this study of a re-irradiation with single radiosurgery or
      hypofractionated intensity modulated radiation therapy (IMRT) with or without temozolomide.

      Objective of the study is evaluating efficacy and safety of re-irradiation for patients with
      recurrent high grade gliomas after other treatment.
    
  